《大行報告》瑞信上調安踏(02020.HK)目標價至130元 評級「跑贏大市」
瑞信發表報告指,在內地體育用品股覆蓋範圍內,更傾向於國產品牌而非代工企業。該行認為內地明年將引領全球經濟復甦,而代工企業則要面臨美國和歐盟的經濟衰退帶來的挑戰。該行首選安踏(02020.HK)和李寧(02331.HK),其次為特步(01368.HK),然後是申州國際(02313.HK)和滔搏(06110.HK)。
報告指,在線下市場正常化下,安踏可能在短期內繼續引領反彈。但當市場拐點明確時,關注點將轉移到增長前景上,由於對Fila增長的擔憂,屆時安踏的表現可能會不及李寧。該行上調安踏目標價由115元至130元,評級「跑贏大市」
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.